Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors

[1]  F. Di Fioré,et al.  Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  V. Tjan-Heijnen,et al.  Diagnostic challenges of respiratory adverse events during everolimus treatment , 2014, Targeted Oncology.

[3]  M. Boermeester,et al.  [Appraising the evidence for new treatments]. , 2014, Nederlands tijdschrift voor geneeskunde.

[4]  A. Gemma,et al.  A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma. , 2013, Japanese journal of clinical oncology.

[5]  S. Krause,et al.  Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors , 2013, Annals of Hematology.

[6]  A. Ravaud,et al.  Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Thigpen.  Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer , 2012 .

[8]  R. Pearson.  Everolimus for Advanced Pancreatic Neuroendocrine Tumors , 2011 .

[9]  G. Gravante,et al.  A systematic review of two different trimetoprim-sulfamethoxazole regimens used to prevent Pneumocystis jirovecii and no prophylaxis at all in transplant recipients: appraising the evidence. , 2009, Transplantation proceedings.

[10]  S. Chevret,et al.  Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. , 2009, Chest.

[11]  R. Motzer,et al.  Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial , 2008, The Lancet.

[12]  H. Einsele,et al.  Central venous catheter-related infections in hematology and oncology , 2008, Annals of Hematology.

[13]  Keiji Fukuda,et al.  Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 , 2002 .

[14]  K. Holmes,et al.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  K. Holmes,et al.  Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America* , 2002, Annals of Internal Medicine.

[16]  P. Souquet,et al.  [Pneumocystis carinii pneumonia in a patient without any sign of immunodeficiency]. , 1992, Presse medicale.